Stock detail
Cytokinetics (CYTK) stock price, chart, and key data
View Cytokinetics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Cytokinetics
CYTK · XNAS
$74.06
+0.60%
+$0.44
Key metrics
52-week range
$16.50 - $7.00
Close price
$73.62
Market cap
$10.2B
P/E ratio
-49.08
Beta
0.56
About the company
Cytokinetics Inc
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$111
16
Buy
/ 17
Recent calls
09/10/2026
RBC Capital
Leonid Timashev
Buy · Price target $112
09/01/2026
Truist Financial
Srikripa Devarakonda
Buy · Price target $112
08/31/2026
Evercore ISI
Cory Kasimov
Buy · Price target $100
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Lisa McClain republican · House · MI-9 spouse |
| $2,002/$16,001/$30,000 |
#2Gilbert Cisneros democrat · House · CA-31 self |
| 27/219/412 |
#3Donald J Trump republican · Executive self |
| 2/13/26 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app